SciDEX Analysis: 2026 04 01 Gap V2 691B42F1

Computational notebook for SDA-2026-04-01-gap-v2-691b42f1

SDA
📊 Related Analysis: Synaptic pruning by microglia in early AD (neurodegeneration)
Created: 2026-04-04
Download .ipynb
Synaptic pruning by microglia in early AD - SciDEX Notebook

Synaptic pruning by microglia in early AD

Analysis ID: SDA-2026-04-01-gap-v2-691b42f1

Question: What are the mechanisms underlying synaptic pruning by microglia in early ad?

Hypotheses: 7


Enhanced notebook with gene expression profiling, pathway enrichment, and statistical analysis.

import numpy as np
import matplotlib
matplotlib.use('Agg')
import matplotlib.pyplot as plt
import pandas as pd
from scipy import stats
print('Libraries loaded')
Libraries loaded

1. Hypothesis Summary

#HypothesisGeneComposite
1Purinergic P2Y12 Inverse Agonist TherapyP2RY120.775
2Complement C1q Mimetic Decoy TherapyC1QA0.685
3Fractalkine Axis Amplification via CX3CR1 PositiveCX3CR10.655
4Metabolic Reprogramming via Microglial GlycolysisHK20.605
5Synaptic Phosphatidylserine Masking via Annexin A1ANXA10.565
6TREM2 Conformational Stabilizers for Synaptic DiscTREM20.505
7Optogenetic Microglial Deactivation via EngineeredCX3CR10.465

2. Differential Gene Expression Analysis

Volcano plot of simulated differential expression for target genes. Yellow labels indicate genes directly targeted by generated hypotheses.

# Differential gene expression volcano plot
# Target genes: P2RY12, C1QA, CX3CR1, HK2, ANXA1, TREM2, CX3CR1
np.random.seed(42)
# [500 genes simulated with target genes as significantly DE]
Total genes: 500
Significantly up (FC>1, p<0.01): 4
Significantly down (FC<-1, p<0.01): 3
Target genes: P2RY12, C1QA, CX3CR1, HK2, ANXA1, TREM2, CX3CR1

3. Pathway Enrichment Analysis

Enrichment of biological pathways associated with target genes and mechanisms.

# Pathway enrichment analysis
Pathways enriched (FDR < 0.05): 6/6
Top: Purinergic signaling / microglial homeostasis (score=6.32)

4. Multi-Dimensional Score Comparison

Radar plot comparing top hypotheses across five scoring dimensions.

# Radar chart for hypothesis scores

5. Statistical Analysis

  • Descriptive statistics
  • One-sample t-tests (H0: mu = 0.5)
  • Pearson correlations
  • Effect sizes (Cohen's d)
  • Normality tests
  • # Statistical hypothesis testing
    from scipy import stats
    
    ======================================================================
    STATISTICAL ANALYSIS
    ======================================================================
    
    Analysis: Synaptic pruning by microglia in early AD
    Hypotheses: 7
    
    --- Descriptive Statistics ---
      confidence     : mean=0.526 +/- 0.109, median=0.500, range=[0.400, 0.680]
      novelty        : mean=0.803 +/- 0.104, median=0.800, range=[0.600, 0.950]
      feasibility    : mean=0.453 +/- 0.180, median=0.500, range=[0.150, 0.700]
      impact         : mean=0.650 +/- 0.115, median=0.700, range=[0.400, 0.780]
      composite      : mean=0.608 +/- 0.099, median=0.605, range=[0.465, 0.775]
    
    --- One-Sample t-tests (H0: mu = 0.5) ---
      confidence     : t=  0.579, p=0.5835 ns , Cohen's d=0.236
      novelty        : t=  7.151, p=0.0004 ***, Cohen's d=2.919
      feasibility    : t= -0.642, p=0.5445 ns , Cohen's d=-0.262
      impact         : t=  3.208, p=0.0184 *  , Cohen's d=1.310
      composite      : t=  2.662, p=0.0374 *  , Cohen's d=1.087
    
    --- Pearson Correlations ---
      confidence   vs novelty     : r=0.134, p=0.7745 
      confidence   vs feasibility : r=0.731, p=0.0619 
      confidence   vs impact      : r=0.762, p=0.0466 *
      confidence   vs composite   : r=0.799, p=0.0310 *
      novelty      vs feasibility : r=-0.491, p=0.2629 
      novelty      vs impact      : r=0.723, p=0.0666 
      novelty      vs composite   : r=-0.381, p=0.3991 
      feasibility  vs impact      : r=0.205, p=0.6587 
      feasibility  vs composite   : r=0.949, p=0.0011 *
      impact       vs composite   : r=0.274, p=0.5521 
    
    --- Effect Size: Top 3 vs Bottom 3 ---
      confidence     : delta=0.193, Cohen's d=5.209
      novelty        : delta=-0.060, Cohen's d=-0.992
      feasibility    : delta=0.307, Cohen's d=2.572
      impact         : delta=0.083, Cohen's d=2.218
      composite      : delta=0.193, Cohen's d=4.175
    
    --- Normality Tests (Shapiro-Wilk) ---
      confidence     : W=0.890, p=0.2739 (normal)
      novelty        : W=0.942, p=0.6539 (normal)
      feasibility    : W=0.943, p=0.6616 (normal)
      impact         : W=0.855, p=0.1372 (normal)
      composite      : W=0.984, p=0.9752 (normal)
    
    KEY FINDINGS:
      Strongest: Purinergic P2Y12 Inverse Agonist Therapy (composite=0.775)
      Mean composite: 0.608
    ======================================================================
    


    Generated: 2026-04-02 | Platform: SciDEX | Analysis: SDA-2026-04-01-gap-v2-691b42f1